Univeristy of Nebraska-Lincoln (UNL) scientist Ana Maria Vélez is pioneering a genetic treatment to contain western corn rootworm. The research seeks to contain agricultural pests by targeting ...

Alnylam Canada ULC is pleased to announce it has received a positive recommendation from Canada's Drug Agency (CDA) for the public reimbursement of its RNAi therapeutic, AMVUTTRA®.1 In December 2025, ...

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

Farmers looking to gain the upper hand over corn rootworm (CRW) pests have new tools to deploy in the field, thanks to Ribonucleic acid interference (RNAi) technology. RNAi works in CRW as it feeds on ...

Johnson & Johnson has presented clinical trial data linking short-term treatment with RNAi therapy JNJ-3989 to sustained reductions in markers of hepatitis B infection. The data drop comes as J&J runs ...

What does Mello’s prize-winning discovery do? RNAi has garnered more than its fair share of attention lately. Being the subject of a Nobel Prize will do that. But it has also left many in the area ...

When it was discovered over a decade ago, RNAi seemed poised to revolutionize medicine. By working to silence defective genes, it has the potential to treat innumerable diseases. Has it delivered? In ...

It is an antiviral mechanism had been found in plants, insects, and nematodes—and mice, too—but it had not been found in humans…until now. Alas, the protective countermeasure, which depends on the ...

RNAi is a powerful tool to used to define cellular mechanisms, and analyze the gene functions of various organisms in laboratories worldwide. Credit: petarg/ Shutterstock.com Fragments of RNA ...

With no single headline event setting the tone, Arrowhead Pharmaceuticals (ARWR) is drawing attention as investors weigh its recent share performance against current financial metrics and the breadth ...